Stay updated on GLE/PIB in Treatment-Naive Cirrhotic HCV: Clinical Trial

Sign up to get notified when there's something new on the GLE/PIB in Treatment-Naive Cirrhotic HCV: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GLE/PIB in Treatment-Naive Cirrhotic HCV: Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    17 days ago
    Change Detected
    Summary
    No significant content changes were observed between the screenshots; the page content remains the same and there are only minor formatting adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-29T02:18:01.000Z thumbnail image
  3. Check
    39 days ago
    Change Detected
    Summary
    Major change: update to v3.2.0 and a prominent notice about government funding impact and operating status; remove the old v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-06T08:11:24.000Z thumbnail image
  4. Check
    47 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T04:30:40.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    Patch-level update: bump Revision from v3.0.1 to v3.0.2 and remove the Back to Top element. No substantive changes to core content, pricing, stock, or time slots.
    Difference
    0.1%
    Check dated 2025-09-14T21:54:36.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-07T18:53:08.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of numerous location details across various countries, while also removing outdated location entries and some medical conditions. The facility name and specific conditions related to glecaprevir and pibrentasvir have been added, indicating a focus on updated medical information.
    Difference
    7%
    Check dated 2025-08-31T12:22:34.000Z thumbnail image

Stay in the know with updates to GLE/PIB in Treatment-Naive Cirrhotic HCV: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GLE/PIB in Treatment-Naive Cirrhotic HCV: Clinical Trial page.